Exclusive-Kimberly-Clark readies EU remedies in bid for Kenvue deal, sources say

BRUSSELS, Sept 14 (Reuters) – Kimberly-Clark is readying concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)